Brodalumab, a Human Anti-Interleukin-17 Receptor A Monoclonal Antibody, Shows Low Immunogenicity in Patients with Moderate-to-Severe Psoriasis. J of Skin [Internet]. 2018 Feb. 23 [cited 2026 May 24];2(S1):S1. Available from: https://skin.dermsquared.com/skin/article/view/254